Healthy Extracts (HYEX) Change in Receivables (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Change in Receivables came in at $119443.0 in Q4 2025, up 1463.19% year-on-year from $7641.0 in Q4 2024, and up 337.78% quarter-over-quarter from $27284.0 in Q3 2025.
Healthy Extracts (HYEX) Change in Receivables (2015 - 2025) Analysis & Trends
Healthy Extracts' Change in Receivables history runs 11 years deep, the most recent figure standing at $119443.0 for Q4 2025.
- On a quarterly basis, Change in Receivables rose 1463.19% year-over-year to $119443.0 in Q4 2025; TTM through Dec 2025 was $139703.0, a 818.75% increase from a year earlier, with the FY2025 full-year figure at $139703.0, up 818.75% from the prior year.
- Change in Receivables advanced to $119443.0 in Q4 2025 per HYEX's latest filing, from $27284.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $119443.0 in Q4 2025 and bottomed at -$78783.0 in Q4 2023.
- The 5-year median for Change in Receivables is -$6030.5 (2023), against an average of $6871.6.
- Across the five-year window, Change in Receivables sank 1663.78% in 2023 and surged 1463.19% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $49755.0 in 2021, then plunged by 89.87% to $5038.0 in 2022, then sank by 1663.78% to -$78783.0 in 2023, then surged by 88.88% to -$8762.0 in 2024, then jumped by 1463.19% to $119443.0 in 2025.
- Per Business Quant, the three latest HYEX Change in Receivables figures stand at $119443.0 (Q4 2025), $27284.0 (Q3 2025), and -$66001.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 119,443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 119,443.00 |
| Dec 31, 2025 | 119,443.00 |
| Sep 30, 2025 | 27,284.00 |
| Sep 30, 2025 | 27,284.00 |
| Jun 30, 2025 | -66,001.00 |
| Jun 30, 2025 | -66,001.00 |
| Mar 31, 2025 | 58,977.00 |
| Mar 31, 2025 | 58,977.00 |
| Dec 31, 2024 | -8,762.00 |
| Dec 31, 2024 | -8,762.00 |
| Sep 30, 2024 | -70,795.00 |
| Sep 30, 2024 | -70,795.00 |
| Jun 30, 2024 | 66,505.00 |
| Jun 30, 2024 | 66,505.00 |
| Mar 31, 2024 | -6,385.00 |
| Mar 31, 2024 | -6,385.00 |
| Dec 31, 2023 | -78,783.00 |
| Dec 31, 2023 | -78,783.00 |
| Sep 30, 2023 | -5,676.00 |
| Sep 30, 2023 | -5,676.00 |